Credit: Teva. The generic product is supplied in a prefilled, single-patient-use pen. Teva has launched an authorized generic version of Victoza ® (liraglutide injection). Liraglutide is a ...

Victoza (liraglutide) is a prescription drug used to treat type 2 diabetes. Doctors also prescribe it to lower the risk of cardiovascular problems in people with both type 2 diabetes and heart failure ...

Victoza (liraglutide) is a prescription drug used to help manage type 2 diabetes and reduce the risk of certain diabetes-related heart problems. Victoza is given as a daily injection under the skin.

Saxenda and Victoza are brand-name injection pens that contain the same active drug, liraglutide. Saxenda is used for weight management. Victoza is used to treat type 2 diabetes and to lower the risk ...

The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the treatment ...

No-moat Teva announced on June 24 that it launched an authorized generic version of Victoza (liraglutide 1.8mg) in the US. Victoza, made by Novo Nordisk, brought in a little over $500 million in ...

According to the Company, the generic product will launch immediately. The Food and Drug Administration (FDA) has approved Liraglutide Injection, the first generic version of Victoza ®. Liraglutide is ...

COPENHAGEN, May 10 (Reuters) - World no. 1 insulin maker Novo Nordisk expects to launch its new potential blockbuster drug Victoza in Mexico and India in the June-July period, a senior executive told ...